Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-13 Purchase | 2025-01-15 4:08 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 20,967 | $17.47 | $366,354 | 9,391,955 (Indirect Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 4,875 | $16.78 | $81,790 | 62,258 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 1,880 | $16.78 | $31,542 | 35,393 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 2,550 | $16.78 | $42,783 | 53,490 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 1,797 | $16.78 | $30,149 | 40,226 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:04 pm | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 17,271 | $16.78 | $289,764 | 204,096 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:04 pm | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 7,989 | $16.78 | $134,036 | 94,811 (Direct) | View |
| 2024-12-19 Purchase | 2024-12-23 5:20 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 52,189 | $18.49 | $965,021 | 9,368,388 (Indirect Direct) | View |
| 2024-12-09 Sale | 2024-12-11 4:28 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $25.26 | $345,134 | 212,132 (Direct) | View |
| 2024-11-19 Sale | 2024-11-21 6:52 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $16.78 | $649,030 | 400,600 (Direct) | View |
| 2024-11-14 Purchase | 2024-11-18 7:35 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 431,940 | $17.07 | $7,373,527 | 9,316,199 (Indirect Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:32 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $17.46 | $1,438,038 | 536,257 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:28 pm | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $16.5 | $907,533 | 99,329 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:23 pm | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $16.79 | $875,042 | 222,869 (Direct) | View |
| 2024-10-02 Purchase | 2024-10-04 5:58 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 205,721 | $20.87 | $4,293,545 | 12,759,887 (Indirect Direct) | View |
| 2024-08-12 Purchase | 2024-08-14 4:43 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 8,016 | $12.72 | $101,968 | 6,319,038 (Indirect Direct) | View |
| 2024-08-12 Purchase | 2024-08-14 4:41 pm | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 7,500 | $12.7 | $95,250 | 29,366 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-10 Exercise | 2025-01-13 4:09 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 9,000 | $0 | 129,922 (Direct) | View |
| 2025-01-10 Exercise | 2025-01-13 4:09 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 9,000 | $3.23 | 129,922 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 226,600 | $0 | 589,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 63,500 | $0 | 103,440 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 63,500 | $0 | 89,423 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 86,600 | $0 | 271,066 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | ZENNER PATRICK J Director | 10,400 | $0 | 25,774 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 75,000 | $0 | 93,273 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner | 10,400 | $0 | 5,072,037 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 10,400 | $0 | 32,166 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 10,400 | $0 | 9,378,788 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Malik Kemal Director | 10,400 | $0 | 16,333 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 63,500 | $0 | 114,533 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 10,400 | $0 | 736,201 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | COX CARRIE SMITH Director | 10,600 | $0 | 31,895 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:19 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | DeSilva Nishan M Director | 10,400 | $0 | 24,166 (Direct) | View |
| 2024-12-26 Gift | 2024-12-30 4:14 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 20,000 | $0 | 725,801 (Direct) | View |
| 2024-12-26 Exercise | 2024-12-30 4:11 pm | N/A 2031-04-25 | Cartesian Therapeutics Inc. | RNAC | English Emily SVP, Head of Manufacturing | 7,650 | $0 | 75,292 (Direct) | View |
| 2024-12-26 Exercise | 2024-12-30 4:11 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily SVP, Head of Manufacturing | 7,650 | $3.3 | 75,292 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-11 4:28 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $0 | 212,132 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-11 4:28 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $1.41 | 212,132 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $0 | 400,600 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $1.41 | 400,600 (Direct) | View |
| 2024-11-19 Gift | 2024-11-21 6:51 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 28,821 | $0 | 745,801 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $0 | 116,372 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $3.23 | 116,372 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $0 | 536,257 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $1.41 | 536,257 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:28 pm | N/A 2031-09-12 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $0 | 99,329 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:28 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $3.23 | 99,329 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $0 | 222,869 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $3.23 | 222,869 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:53 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner | 1,563,924 | $0 | 5,118,039 (Indirect) | View |
| 2024-10-11 Exercise | 2024-10-15 4:43 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Hoge Elizabeth Seven One Eight Three Four Irrevocable Trust 10% Owner | 1,563,924 | $0 | 5,118,039 (Indirect) | View |
| 2024-10-02 Other | 2024-10-04 5:58 pm | 2022-04-11 2027-04-11 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 4,505,650 | $0 | 12,759,887 (Indirect) | View |
| 2024-09-25 Exercise | 2024-09-27 4:13 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 2,359,500 | $0 | 6,029,547 (Direct) | View |
| 2024-07-02 Option Award | 2024-07-05 4:02 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 2,359,500 | $20 | 7,949,161 (Direct) | View |